Leggit Jeffrey C
Medical Corps, United States Army.
Curr Sports Med Rep. 2011 Mar-Apr;10(2):109-14. doi: 10.1249/JSR.0b013e31820f31ca.
Athletes are susceptible to upper gastrointestinal complaints just like the general population. The most common etiologies are gastroesophageal reflux disease (GERD) and functional heartburn. If the signs and symptoms are compatible with GERD and the clinician has considered more serious pathology unlikely, a therapeutic trial with a proton pump inhibitor (PPI) can be initiated without further evaluation. The treatment for pure exertional GERD is similar but is guided by expert opinion only. Surgery has a limited role, but new techniques are evolving that may change the risk-to-benefit ratio. Chronic PPI therapy generally is safe, but there is a small risk of osteoporosis with concomitant fracture. There is no evidence for routine endoscopic screening for Barrett's esophagus or esophageal adenocarcinoma. For those who do not respond to treatment, the most likely diagnosis is functional heartburn. This is a diagnosis of exclusion, and referral to gastroenterology is warranted for diagnostic testing.
与普通人群一样,运动员也易患上消化道疾病。最常见的病因是胃食管反流病(GERD)和功能性烧心。如果体征和症状与GERD相符,且临床医生认为不太可能存在更严重的病变,则可在不进行进一步评估的情况下启动质子泵抑制剂(PPI)治疗试验。单纯运动性GERD的治疗方法类似,但仅以专家意见为指导。手术的作用有限,但新技术不断发展,可能会改变风险效益比。长期PPI治疗一般是安全的,但存在伴随骨折的骨质疏松小风险。没有证据支持对巴雷特食管或食管腺癌进行常规内镜筛查。对于治疗无反应者,最可能的诊断是功能性烧心。这是一种排除性诊断,有必要转诊至胃肠病科进行诊断测试。